www.fdanews.com/articles/122995-amgen-array-biopharma-enter-development-agreement

Amgen, Array BioPharma Enter Development Agreement

December 15, 2009

Biotech drug developer Amgen Inc. has entered an agreement with Array BioPharma Inc. to develop a potential treatment for type 2 diabetes, the companies said.
TheStreet